Trending stocks: Cadila Healthcare shares flat in early trade

NEW DELHI: Shares of Cadila Healthcare Ltd. traded 0.13 per cent up in Friday 's trade at 10:04 am.

Around 499506 shares changed hands on the counter. The stock opened at Rs 263.85 and touched an intraday high and low of Rs 267.45 and Rs 258.3 , respectively, in the session so far.

The stock quoted a 52-week high of Rs 404.0 and a 52-week low of Rs 206.5 .

The drug maker said it has received final approval from the US health regulator to market generic Lamotrigine extended-release tablets, used to treat certain types of seizures.

Financials
Cadila Healthcare Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 27011.45 Crore) operating in Pharmaceuticals sector.

For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 3534.50 Crore, up 8.95 % from last quarter Sales of Rs 3244.20 Crore and up .52 % from last year same quarter Sales of Rs 3516.10 Crore Company has reported net profit after tax of Rs 364.40 Crore in latest quarter.

Cadila Healthcare Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 6207.00 Crore to Sales Value (95.59 % of Total Sales), Export Incentives which contributed Rs 169.30 Crore to Sales Value (2.60 % of Total Sales) and Other Operating Revenue which contributed Rs 116.40 Crore to Sales Value (1.79 % of Total Sales)for the year ending 31-Mar-2019.

Promoters holding
Promoters held 74.8757 per cent stake in the company as of Dec 2019 . For the quarter ended Dec 2019 , the company reported a net sales of Rs 3534.5 crore and net profit of Rs 364.4 crore.

Valuation ratio
It quoted a price-to-earnings ratio of 21.51 and price to book value of 2.3 .